Congratulations to Joseph Victor and the entire RareCyte, Inc. team on successfully completing your recent financing round. The funding will enable RareCyte to expand their Orion Spatial Biology platform by commercializing new multiplex assays, reagent products, software applications, and developing spatial biology and liquid biopsy assays. Additionally, it will support RareCyte's global commercial expansion, particularly in regions outside the US. "We are honored to have Forest Road join an outstanding group of investors led by Arboretum Ventures and F-Prime Capital.” said Joseph Victor, RareCyte President and CEO. “This funding will allow RareCyte to accelerate the development of our broad menu of Spatial Biology assays, applications, and software products to benefit our customers worldwide”. Learn more: https://lnkd.in/euEsbJJ5 The Forest Road Company │Arboretum Ventures │ HealthQuest Capital │ 5AM Ventures │ Agilent Technologies │ Sheatree Capital │ GKCC LLC │ Ron Seubert Robert Weisskoff, Ph.D. #Healthcare #Biology
Great news! Congratulations, Joseph Victor and team!
Congrats!
Senior VP @ Visiopharm | Pro-bono Editorial Board Member | Phenoplex strategic development, collaborations, and partnerships
3moCongratulations!